Skip to content

The DISCOVER Trial (Diagnosis of Infection in Stem Cell Transplant Patients OVER Time)

The DISCOVER Trial (Diagnosis of Infection in Stem Cell Transplant Patients OVER Time)

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02804464
Acronym
DISCOVER
Enrollment
70
Registered
2016-06-17
Start date
2016-07-31
Completion date
2023-07-31
Last updated
2023-03-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bone Marrow Transplant Infection

Brief summary

Demonstrate that the Karius Infectious Disease Diagnostic Sequencing Assay performed on plasma can accurately detect the microbiologic etiology in febrile allogeneic stem-cell transplant patients when compared with standard clinical diagnostics

Interventions

None listed

Sponsors

University of California, San Francisco
CollaboratorOTHER
Karius, Inc.
Lead SponsorINDUSTRY

Study design

Observational model
CASE_ONLY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* 18 years of age or older * Patients who plan on undergoing an allogeneic stem cell transplant and are admitted to UCSF Medical Center.

Exclusion criteria

* Inability to provide informed consent and comply with study-related procedures

Design outcomes

Primary

MeasureTime frame
Demonstrate that the Karius Infectious Disease Diagnostic Sequencing Assay performed on plasma can accurately detect the microbiologic etiology in febrile allogeneic stem-cell transplant patients when compared with standard clinical diagnostics.7 days

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026